Journal Information
Vol. 43. Issue S3.
Pages S52 (November 2021)
Share
Share
Download PDF
More article options
Vol. 43. Issue S3.
Pages S52 (November 2021)
PP 52
Open Access
PILOMATRIX CARCINOMA WAS BEYOND ANY EXPECTATIONS: A CASE REPORT OF CARCINOMA CLINICIAN SHOULD BE AWARE OF IT
Visits
892
Abdalraouf Omar1, Suad Elnnami2, Ibtihaj Hassan3
1 Tripoli University Hospital and Albadry policlinic
2 Tripoli University Hospital and University of Tripoli
3 Tripoli University Hospital
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 43. Issue S3
More info
Introduction

Pilomatrix carcinoma is a rare cutaneous tumor derived from follicular matrix with about 150 reported cases and it is considered as locally aggressive tumor with a tendency to recur. In addition to lymph node metastases and poor prognosis, it is non-chemotherapy responding in systemic metastasis.

Method and result

A 37-year-old Libyan man presented with two large, coalesced nodules in the face measuring about 3*2 cm and 3*3 cm, treated as a case of lipoma by surgical excision based on clinical diagnosis, reappearing of larger nodule 9*6*4 cm involving almost all the left check, surgical excision was done with histopathological features of pilomatrix carcinoma infiltrating to the subcutaneous adipose tissue and deep striated muscle with no clear margins. Conventional radiotherapy by electron beam was started using the linear accelerating machine, with total radiotherapy dose 60 gray (Gy) in 30 fraction for six weeks. No local recurrences, nor lymph node or systemic metastasis since June 2020.

Conclusion

Pilomatrix carcinoma must always be considered in the differential diagnosis of nodular tumors of the head-and-neck due to high recurrence rate after simple excision. Furthermore, local radiotherapy post incomplete surgical excision is the best adjuvant therapy.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools